Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

BACKGROUND: An important component of the RAS signalling pathway, the RAS p21 oncogene, is frequently hyperactivated in breast cancer. Its expression in tumor tissue has been linked to poor clinical outcome. This study was designed to evaluate the clinical relevance of RAS p21 levels in peripheral b...

Descripción completa

Detalles Bibliográficos
Autores principales: Banys-Paluchowski, Malgorzata, Fehm, Tanja, Janni, Wolfgang, Aktas, Bahriye, Fasching, Peter A., Kasimir-Bauer, Sabine, Milde-Langosch, Karin, Pantel, Klaus, Rack, Brigitte, Riethdorf, Sabine, Solomayer, Erich-Franz, Witzel, Isabell, Müller, Volkmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941516/
https://www.ncbi.nlm.nih.gov/pubmed/29739347
http://dx.doi.org/10.1186/s12885-018-4282-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941516/
https://www.ncbi.nlm.nih.gov/pubmed/29739347
http://dx.doi.org/10.1186/s12885-018-4282-0

Ejemplares similares